John, N; Carroll, A; Brownlee, WJ; Chataway, J; (2019) Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis. [Letter]. Journal of Neurology, Neurosurgery & Psychiatry 10.1136/jnnp-2019-320687. (In press).